Skip to main content
. Author manuscript; available in PMC: 2012 Jul 20.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2010 Apr 8;78(5):1387–1393. doi: 10.1016/j.ijrobp.2009.09.070

Table 3.

Incidence of Grade 2 and 3 toxicity by group

In-field relapse (n = 11) Out-of-field relapse (n = 25) Total (n = 36)
n (%) n (%) n (%)
Cough
 Grade 2 0 3 (12%) 3 (8%)
 Grade 3 0 1 (4%) 1 (3%)
Pneumonitis
 Grade 2 5 (45%) 6 (24%) 11 (36%)
 Grade 3 0 7 (28%) 7 (28%)
Esophagitis
 Grade 2 1 (9%) 1 (4%) 2 (6%)
 Grade 3 1 (9%) 2* (8%) 3 (8%)
Skin
 Grade 2 1 (9%) 0 1 (3%)
 Grade 3 2 (18%) 0 2 (6%)
Chest Wall Pain
 Not requiring narcotic 4 (36%) 1 (4%) 5 (14%)
 Requiring narcotic 3 (27%) 3 (12%) 6 (17%)

No Grade 4 or 5 toxicity was seen.

*

In addition, one patient developed esophageal stricture requiring dilation.